封面
市场调查报告书
商品编码
1697358

深层脑部刺激器市场:2025-2030 年预测

Deep Brain Stimulation Devices Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

深部脑部刺激 (DBS) 设备市场预计将从 2025 年的 1,979,749,000 美元增长到 2030 年的 3,237,249,000 美元,预测期内的复合年增长率为 10.33%。

由于神经系统疾病盛行率不断上升、技术进步以及人们对 DBS 疗法的认识不断提高,全球深部脑部刺激设备市场预计将以显着的速度成长。

市场趋势

  • 神经系统疾病盛行率不断上升:帕金森氏症、自发性震颤和肌张力不全症等神经系统疾病盛行率不断上升是市场成长的主要驱动力。例如,帕金森基金会估计,全球有超过 1,000 万人患有帕金森氏症。中风也是一个主要因素,预计全球整体四分之一的 25 岁及以上人群在其一生中会经历中风。
  • 技术进步:持续的技术进步,包括改进的导线设计、植入式脉衝产生器、远端监控能力和增强的运算能力,正在提高 DBS 治疗的有效性和安全性。最近的创新包括具有远端编程功能的紧凑型可充电 DBS 系统。
  • 提高意识和接受度:在政府措施和政策的推动下,全球对 DBS 疗法的认识和接受度不断提高,这有助于市场扩张。
  • 微创手术:对微创手术的不断增长的需求也推动了市场的成长。 Picostim DBS 系统是一种新型微型 DBS 设备,旨在减少与传统 DBS 手术相关的併发症和成本。

地理视角

  • 北美:由于技术进步不断加快、研发生态系统强大以及美国主要市场参与者的稳固地位,北美预计将主导 DBS 设备市场。
  • 欧洲:由于医疗保健领域的进步以及对微创医疗干预的关注,欧洲预计将实现显着成长。
  • 亚太地区:受可支配收入增加、人们对神经系统疾病的认识不断提高以及政府对医疗保健计划的支持推动,亚太地区预计将出现最高增长。
  • 南美洲、中东和非洲:由于医疗保健领域的技术进步率较低,预计南美洲、中东和非洲的成长速度将放缓。

为什么要购买这份报告?

  • 深刻分析:获得涵盖主要和新兴地区的深入市场洞察,重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局:了解全球主要企业采取的策略策略,并了解正确策略带来的潜在市场渗透。
  • 市场趋势和驱动因素:探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
  • 可行的建议:利用洞察力做出策略决策,在动态环境中开闢新的业务流和收益。
  • 适用范围广:对于新兴企业、科学研究机构、顾问公司、中小企业、大型企业都有利且划算。

它有什么用途?

产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的历史资料与预测
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争定位、策略和市场占有率分析
  • 细分和区域分析,包括收益成长和预测国家
  • 公司概况(包括主要趋势)

深层脑部刺激器市场分析为以下几个部分:

按应用

  • 帕金森氏症
  • 癫痫
  • 自发性震颤
  • 肌张力不全症
  • 其他(强迫性精神官能症、妥瑞症)

依产品类型

  • 单通道深层脑部刺激器
  • 双通道深层脑部刺激器

按最终用户

  • 医院
  • 门诊手术中心
  • 神经科诊所

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 其他的
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 南美洲
  • 韩国
  • 澳洲
  • 新加坡
  • 印尼
  • 其他的
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 中东和非洲
  • 沙乌地阿拉伯
  • 阿联酋等

目录

第一章执行摘要

  • 市场概览
  • 主要趋势和见解
  • 市场规模及预测

第 2 章 简介

  • 定义和范围
  • 都市化加速
  • 永续性的重要性

第三章 市场动态

  • 市场成长动力
  • 挑战与障碍
  • 新兴市场机会
  • 监管和环境因素

第四章 細項分析

  • 按应用
    • 帕金森氏症
    • 癫痫
    • 自发性震颤
    • 肌张力不全症
    • 其他的
  • 依产品类型
    • 单通道深层脑部刺激器
    • 双通道深层脑部刺激器
  • 按最终用户
    • 医院
    • 门诊手术中心
    • 神经科诊所
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东和非洲

第五章 竞争格局

  • 主要市场参与者
  • 公司简介及策略
  • 市场占有率分析

第六章 市场趋势与创新

  • 神经系统疾病发生率增加。
  • 技术进步仍在持续。
  • 医疗保健技术的创新和投资。
  • 提高全球对深部脑部刺激的接受度和认识。

第七章 市场展望与预测

  • 市场规模和成长预测
  • 区域市场展望

第八章法规结构

  • 智慧财产
  • 资料隐私和安全

第九章案例研究与产业应用

  • 帕金森氏症和癫痫治疗设备
  • 单通道和双通道深层脑部刺激器
  • 神经学应用的仪器和设备

第十章结论与建议

  • 关键要点
  • 向相关人员提出的策略建议

第十一章 附录

  • 调查方法
  • 资料来源与参考文献
  • 词彙表
简介目录
Product Code: KSI061616645

The Deep Brain Stimulation (DBS) Devices Market is set to witness robust growth at a CAGR of 10.33% during the forecast period to be worth US$3,237.249 million in 2030 from US$1,979.749 million in 2025.

The global deep brain stimulation (DBS) devices market is poised for substantial growth, driven by the increasing prevalence of neurological disorders, technological advancements, and growing awareness of DBS therapy.

Market Trends

  • Increasing Prevalence of Neurological Disorders: The rising incidence of neurological conditions such as Parkinson's disease, essential tremors, and dystonia is a primary driver of market growth. For instance, the Parkinson's Foundation estimates that over 10 million individuals worldwide suffer from Parkinson's disease. Stroke is another major factor; globally, one in every four people aged 25 or older is expected to experience a stroke in their lifetime.
  • Technological Advancements: Ongoing technological advancements, including improvements in lead design, implantable pulse generators, remote monitoring capabilities, and increased computing power, are enhancing the effectiveness and safety of DBS therapy. Recent innovations include smaller, rechargeable DBS systems with remote programming capabilities.
  • Growing Awareness and Acceptance: Increasing global awareness and acceptance of DBS therapy, facilitated by governmental initiatives and policies, are contributing to market expansion.
  • Minimally Invasive Procedures: Escalating demand for minimally invasive procedures is also propelling the market growth. A novel miniaturized DBS device, the Picostim DBS system, aims to mitigate complications and reduce costs associated with traditional DBS surgery.

Geographical Outlook

  • North America: North America is expected to dominate the DBS devices market due to increasing technological advancements, a strong research and development ecosystem, and the established presence of major market players in the U.S.
  • Europe: Europe is projected to experience significant growth due to advancements in its healthcare sector and a focus on minimally invasive medical interventions. Increasing government spending on mental health services is also a driving factor in the UK.
  • Asia-Pacific: The Asia-Pacific region is expected to witness the highest growth, driven by increasing disposable incomes, growing awareness of neurological conditions, and government support for healthcare initiatives.
  • South America and MEA: South America and the Middle East & Africa are expected to experience slower growth due to a lower rate of technological advancements in their healthcare sectors.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Deep Brain Stimulation Devices Market is analyzed into the following segments:

By Application

  • Parkinson's Disease
  • Epilepsy
  • Essential Tremor
  • Dystonia
  • Others (OCD and Tourette syndrome)

By Product Type

  • Single-channel Deep Brain Stimulators
  • Dual-channel Deep Brain Stimulators

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Neurological Clinics

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Others
  • South America
  • Brazil
  • Argentina
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

  • 1.1. Market Overview
  • 1.2. Key Trends and Insights
  • 1.3. Market Size and Forecast

2. INTRODUCTION

  • 2.1. Definition and Scope
  • 2.2. Growing urbanization
  • 2.3. Importance of sustainability

3. MARKET DYNAMICS

  • 3.1. Drivers of Market Growth
  • 3.2. Challenges and Barriers
  • 3.3. Opportunities in Emerging Markets
  • 3.4. Regulatory and Environmental Factors

4. SEGMENTATION ANALYSIS

  • 4.1. By Application
    • 4.1.1. Parkinson's Disease
    • 4.1.2. Epilepsy
    • 4.1.3. Essential Tremor
    • 4.1.4. Dystonia
    • 4.1.5. Others
  • 4.2. By Product Type
    • 4.2.1. Single-channel Deep Brain Stimulators
    • 4.2.2. Dual-channel Deep Brain Stimulators
  • 4.3. By End-User
    • 4.3.1. Hospitals
    • 4.3.2. Ambulatory Surgical Centers
    • 4.3.3. Neurological Clinics
  • 4.4. By Geography
    • 4.4.1. North America
      • 4.4.1.1. United States
      • 4.4.1.2. Canada
      • 4.4.1.3. Mexico
    • 4.4.2. Europe
      • 4.4.2.1. United Kingdom
      • 4.4.2.2. Germany
      • 4.4.2.3. France
      • 4.4.2.4. Spain
      • 4.4.2.5. Others
    • 4.4.3. Asia Pacific
      • 4.4.3.1. China
      • 4.4.3.2. Japan
      • 4.4.3.3. India
      • 4.4.3.4. South Korea
      • 4.4.3.5. Australia
      • 4.4.3.6. Singapore
      • 4.4.3.7. Indonesia
      • 4.4.3.8. Others
    • 4.4.4. South America
      • 4.4.4.1. Brazil
      • 4.4.4.2. Argentina
      • 4.4.4.3. Others
    • 4.4.5. Middle East & Africa
      • 4.4.5.1. Saudi Arabia
      • 4.4.5.2. UAE
      • 4.4.5.3. Others

5. COMPETITIVE LANDSCAPE

  • 5.1. Key Market Players
  • 5.2. Company Profiles and Strategies
  • 5.3. Market Share Analysis

6. MARKET TRENDS AND INNOVATIONS

  • 6.1. Growing prevalence of neurological disorders.
  • 6.2. Increasing technological advancement.
  • 6.3. Innovations and investments in healthcare technology.
  • 6.4. Growing global acceptance and awareness of deep brain stimulation.

7. MARKET OUTLOOK AND FORECAST

  • 7.1. Market Size and Growth Projections
  • 7.2. Regional Market Outlook

8. REGULATORY FRAMEWORK

  • 8.1. Intellectual Property Rights
  • 8.2. Data Privacy and Security

9. CASE STUDIES AND INDUSTRY APPLICATIONS

  • 9.1. Parkinson's and Epilepsy devices
  • 9.2. Single and Dual-channel Deep Brain Stimulators
  • 9.3. Equipment and Devices for neurological application

10. CONCLUSION AND RECOMMENDATIONS

  • 10.1. Key Takeaways
  • 10.2. Strategic Recommendations for Stakeholders

11. APPENDICES

  • 11.1. Research Methodology
  • 11.2. Data Sources and References
  • 11.3. Glossary of Terms